Completed PHASE2 INTERVENTIONAL 4-arm NCT02077920

Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP) (VAP)

Prevention of Ventilator-Associated Pneumonia by Oropharyngeal and Subglottic Decontamination Via Bronchoscopy

Sponsor: General Hospital of Shenyang Military Region

Conditions Ventilator-associated Pneumonia

Interventions 0.9% sodium chloride injection Chlorhexidine Endotracheal tube Fiber bronchoscope

Updated 7 times since 2017 Last updated: Aug 12, 2019 Started: Mar 31, 2014 Primary completion: Jun 30, 2019 Completion: Aug 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Ventilator-associated Pneumonia and is currently completed. General Hospital of Shenyang Military Region leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Sep 2019 — Jan 2021 [monthly]

Completed PHASE2

Status: Unknown Status → Completed
Jun 2018 — Sep 2019 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Mar 2018 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2017 — Mar 2018 [monthly]

Recruiting PHASE2

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

General Hospital of Shenyang Military Region

Data source: General Hospital of Shenyang Military Region

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shenyang, China